| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Structural Biology and Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305
KIR3DL1 and KIR3DL2 are NK cell receptors for polymorphic HLA-B and -A determinants. The proportion of NK cells that bind anti-KIR3DL1-specific Ab DX9 and their level of binding vary between individuals. To determine whether these differences are due to KIR polymorphism, we assessed KIR3D gene diversity in unrelated individuals and families. Both KIR3DL1 and KIR3DL2 are highly polymorphic genes, with KIR3DS1 segregating like an allele of KIR3DL1. A KIR haplotype lacking KIR3DL1 and KIR3DS1 was defined. The two KIR3DL1 alleles of a heterozygous donor were expressed by different, but overlapping, subsets of NK cell clones. Sequence variation in KIR3DL1 and KIR3DL2 appear distinct; recombination is more evident in KIR3DL1, and point mutation is more evident in KIR3DL2. The KIR3DL1 genotype correlates well with levels of DX9 binding by NK cells, but not with the frequency of DX9-binding cells. Different KIR3DL1 alleles determine high, low, and no binding of DX9 Ab. Consequently, heterozygotes for high and low binding KIR3DL1 alleles have distinct subpopulations of NK cells that bind DX9 at high and low levels, giving characteristic bimodal distributions in flow cytometry. The Z27 Ab gave binding patterns similar to those of DX9. Four KIR3DL1 alleles producing high DX9 binding phenotypes were distinguished from four alleles producing low or no binding phenotypes by substitution at one or more of four positions in the encoded protein: 182 and 283 in the extracellular Ig-like domains, 320 in the transmembrane region, and 373 in the cytoplasmic tail.
This article has been cited by other articles:
|
|
 |
|
  J. S. Miller How killers kill Blood, July 15, 2008; 112(2): 213 - 213. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sharkey, L. Gardner, S. Hiby, L. Farrell, R. Apps, L. Masters, J. Goodridge, L. Lathbury, C. A. Stewart, S. Verma, et al. Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age J. Immunol., July 1, 2008; 181(1): 39 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Thomas, E. Yamada, G. Alter, M. P. Martin, A. A. Bashirova, P. J. Norman, M. Altfeld, P. Parham, S. K. Anderson, D. W. McVicar, et al. Novel KIR3DL1 Alleles and Their Expression Levels on NK Cells: Convergent Evolution of KIR3DL1 Phenotype Variation? J. Immunol., May 15, 2008; 180(10): 6743 - 6750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pascal, E. Yamada, M. P. Martin, G. Alter, M. Altfeld, J. A. Metcalf, M. W. Baseler, J. W. Adelsberger, M. Carrington, S. K. Anderson, et al. Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection J. Immunol., August 1, 2007; 179(3): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Thananchai, G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B J. Immunol., January 1, 2007; 178(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. O'Connor, K. J. Guinan, R. T. Cunningham, D. Middleton, P. Parham, and C. M. Gardiner Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells J. Immunol., January 1, 2007; 178(1): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yawata, N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function J. Exp. Med., March 20, 2006; 203(3): 633 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Carr, M. J. Pando, and P. Parham KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand J. Immunol., October 15, 2005; 175(8): 5222 - 5229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Hsu, C. A. Keever-Taylor, A. Wilton, C. Pinto, G. Heller, K. Arkun, R. J. O'Reilly, M. M. Horowitz, and B. Dupont Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes Blood, June 15, 2005; 105(12): 4878 - 4884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Leung, R. Iyengar, B. Triplett, V. Turner, F. G. Behm, M. S. Holladay, J. Houston, and R. Handgretinger Comparison of Killer Ig-Like Receptor Genotyping and Phenotyping for Selection of Allogeneic Blood Stem Cell Donors J. Immunol., May 15, 2005; 174(10): 6540 - 6545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Draghi, N. Yawata, M. Gleimer, M. Yawata, N. M. Valiante, and P. Parham Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I Blood, March 1, 2005; 105(5): 2028 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Bergen, A. Thompson, A. van der Slik, T. H. M. Ottenhoff, J. Gussekloo, and F. Koning Phenotypic and Functional Characterization of CD4 T Cells Expressing Killer Ig-Like Receptors J. Immunol., December 1, 2004; 173(11): 6719 - 6726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Saruhan-Direskeneli, F. A. Uyar, A. Cefle, S. C. Onder, E. Eksioglu-Demiralp, S. Kamali, M. Inanc, L. Ocal, and A. Gul Expression of KIR and C-type lectin receptors in Behcet's disease Rheumatology, April 1, 2004; 43(4): 423 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Leung, R. Iyengar, V. Turner, P. Lang, P. Bader, P. Conn, D. Niethammer, and R. Handgretinger Determinants of Antileukemia Effects of Allogeneic NK Cells J. Immunol., January 1, 2004; 172(1): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pando, C. M. Gardiner, M. Gleimer, K. L. McQueen, and P. Parham The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1 J. Immunol., December 15, 2003; 171(12): 6640 - 6649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Artavanis-Tsakonas, K. Eleme, K. L. McQueen, N. W. Cheng, P. Parham, D. M. Davis, and E. M. Riley Activation of a Subset of Human NK Cells upon Contact with Plasmodium falciparum-Infected Erythrocytes J. Immunol., November 15, 2003; 171(10): 5396 - 5405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stewart, J. van Bergen, and J. Trowsdale Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters J. Immunol., June 15, 2003; 170(12): 6073 - 6081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Shilling, K. L. McQueen, N. W. Cheng, J. A. Shizuru, R. S. Negrin, and P. Parham Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood, May 1, 2003; 101(9): 3730 - 3740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Musette, L. Michel, F. Jean-Louis, M. Bagot, and A. Bensussan Polymorphic expression of CD158k/p140/KIR3DL2 in Sezary patients Blood, February 1, 2003; 101(3): 1203 - 1203. [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Chan, Z. B. Kurago, C. A. Stewart, M. J. Wilson, M. P. Martin, B. E. Mace, M. Carrington, J. Trowsdale, and C. T. Lutz DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells J. Exp. Med., January 20, 2003; 197(2): 245 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R. J. O'Reilly, and B. Dupont Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets J. Immunol., November 1, 2002; 169(9): 5118 - 5129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Santourlidis, H.-I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells J. Immunol., October 15, 2002; 169(8): 4253 - 4261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. I. Khakoo, R. Geller, S. Shin, J. A. Jenkins, and P. Parham The D0 Domain of KIR3D Acts as a Major Histocompatibility Complex Class I Binding Enhancer J. Exp. Med., October 7, 2002; 196(7): 911 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Guethlein, L. R. Flodin, E. J. Adams, and P. Parham NK Cell Receptors of the Orangutan (Pongo pygmaeus): A Pivotal Species for Tracking the Coevolution of Killer Cell Ig-Like Receptors with MHC-C J. Immunol., July 1, 2002; 169(1): 220 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Shilling, N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham Genetic Control of Human NK Cell Repertoire J. Immunol., July 1, 2002; 169(1): 239 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Shilling, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, R. Rodriguez, D. Tyan, and P. Parham Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype J. Immunol., March 1, 2002; 168(5): 2307 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Shum, L. R. Flodin, D. G. Muir, R. Rajalingam, S. I. Khakoo, S. Cleland, L. A. Guethlein, M. Uhrberg, and P. Parham Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes J. Immunol., January 1, 2002; 168(1): 240 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Allen, T. Raine, A. Haude, J. Trowsdale, and M. J. Wilson Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures J. Immunol., November 15, 2001; 167(10): 5543 - 5547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Canavez, N. T. Young, L. A. Guethlein, R. Rajalingam, S. I. Khakoo, B. P. Shum, and P. Parham Comparison of Chimpanzee and Human Leukocyte Ig-Like Receptor Genes Reveals Framework and Rapidly Evolving Genes J. Immunol., November 15, 2001; 167(10): 5786 - 5794. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
